European regulations for first-in-human clinical trials

被引：0
|
作者：
Schriever, J. [1 ]
机构：
[1] Fed Inst Drugs & Med Devices, Unit Clin Trials GCP Inspect, Bonn, Germany
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2007年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
I-17
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [21] The ethics of withdrawal: the case of follow-up from first-in-human clinical trials
    Hug, Kristina
    Johansson, Mats
    [J]. REGENERATIVE MEDICINE, 2017, 12 (01) : 25 - 36
  • [22] EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
    Caroline Stokke
    Silvano Gnesin
    Johannes Tran-Gia
    Francesco Cicone
    Søren Holm
    Marta Cremonesi
    Johan Blakkisrud
    Thomas Wendler
    Nic Gillings
    Ken Herrmann
    Felix M. Mottaghy
    Jonathan Gear
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1268 - 1286
  • [23] Regulatory approach to first-in-human trials with monoclonal antibodies
    Bernardi, Claudio
    [J]. TOXICOLOGY LETTERS, 2009, 189 : S3 - S4
  • [24] FIRST-IN-HUMAN TRIALS: REGULATOR'S PERSPECTIVE IN JAPAN
    Asakura, W.
    Iguchi, T.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 51 - 52
  • [25] Consider drug efficacy before first-in-human trials
    Jonathan Kimmelman
    Carole Federico
    [J]. Nature, 2017, 542 : 25 - 27
  • [26] Consider drug efficacy before first-in-human trials
    Kimmelman, Jonathan
    Federico, Carole
    [J]. NATURE, 2017, 542 (7639) : 25 - 27
  • [27] Choice of starting dose for biopharmaceuticals in first-in-human phase I cancer clinical trials.
    Hansen, Aaron Richard
    Cook, Natalie
    Ricci, M. Stacey
    Razak, Albiruni R. A.
    Le Tourneau, Christophe
    McKeever, Kathleen
    Roskos, Lorin
    Dixit, Rakesh
    Siu, Lillian L.
    Hinrichs, Mary Jane
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Regulatory and nonclinical considerations for translation of gene therapy medicinal products to first-in-human clinical trials
    Montane, J.
    Rayo, M.
    Penon, O.
    Coderch, N.
    Mann, C. J.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A209 - A210
  • [29] The Role of Quantitative Systems Pharmacology in the Design of First-in-Human Trials
    van der Graaf, Piet H.
    Benson, Neil
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 797 - 797
  • [30] Understanding voluntariness of consent in first-in-human cell therapy trials
    Hug, Kristina
    [J]. REGENERATIVE MEDICINE, 2020, 15 (05) : 1647 - 1660
12345